17 Large Cap Stocks Just Made New 52-Week Highs
A list of market leaders shows a clear industry pattern, but one giant’s valuation stands apart.
Merck (MRK), a company with a market value of about $335.8 billion, just hit a new high. It leads a list of 17 Large Cap stocks reaching their strongest price of the past year on Friday.
The list is heavily concentrated in the Financials sector, with 6 names from the Diversified Banks industry and 2 from Asset Management & Custody Banks. But the presence of Merck raises a central question: what does it mean when a list of leaders contains both steady banks and a pharma giant trading at 105.7 times trailing earnings? Here are the names.
The Ten Largest At New Highs
The table below shows the 10 largest of the 17 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| MRK | $335.8 Bil | 0.2% | 5.6% | 6.4% | 69.7% |
| RY | $301.7 Bil | 0.7% | 2.6% | 0.8% | 63.8% |
| SCHW | $194.0 Bil | 1.2% | 3.5% | 8.4% | 17.7% |
| BMO | $131.6 Bil | 0.9% | 2.3% | 2.5% | 67.5% |
| CM | $113.5 Bil | 1.1% | 4.2% | 2.5% | 74.2% |
| BNY | $112.8 Bil | 0.6% | 3.6% | 1.9% | 63.0% |
| BNS | $112.6 Bil | 1.0% | 3.0% | 2.1% | 68.7% |
| PNC | $104.1 Bil | 0.7% | 1.7% | 1.5% | 37.2% |
| USB | $101.7 Bil | 0.4% | 2.3% | 2.2% | 46.0% |
| PSX | $93.9 Bil | 0.4% | 14.6% | 16.0% | 97.1% |
What does a 105.7 P/E ratio tell us at a 52-week high?
Merck’s valuation stands out sharply. The company’s revenue grew 4.6% over the last twelve months and its operating margin is 10.5%. Yet its stock trades at 105.7 times trailing earnings.
Contrast that with another name on the list, Charles Schwab (SCHW). Its revenue grew 20.3% over the same period, and it trades at 19.1 times trailing earnings. Or consider Royal Bank of Canada (RY), with revenue growth of 11.9% and a multiple of 13.6. The market is pricing these new highs very differently.
Is a new high a signal to buy or a warning?
A 52-week-high list is a map of what is working. Strength often persists. But a high is a price, not a verdict on a business’s intrinsic value.
The disciplined move is to treat this list as a starting point for work, not an answer. The key question is always whether the business fundamentals can earn the stock’s new level.
A new high tells you what the market already believes. The harder question is which of these runs management itself is underwriting. Our Guidance Momentum screen tracks exactly that: stocks where the company raised its own forward numbers.
One more pattern worth noticing: 10 of the 17 names are Financials stocks. When a whole group is making new highs together, a financials ETF like XLF is one way to own the group’s strength without betting on which single name leads it from here.
Chasing Highs Is A Reflex. Owning Strength Is A System
A 52-week-high list is seductive: everything on it has been going right. But buying a stock because it is at its high is buying a price, and prices revert; what persists is the quality underneath the run.
The Trefis High Quality (HQ) Portfolio is built to own that quality before and after it makes headlines: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Admire the list; own the system.